Stocks and Investing
Stocks and Investing
Mon, October 21, 2019
[ Mon, Oct 21st 2019
] - WOPRAI
[ Mon, Oct 21st 2019
] - WOPRAI
[ Mon, Oct 21st 2019
] - WOPRAI
[ Mon, Oct 21st 2019
] - WOPRAI
[ Mon, Oct 21st 2019
] - WOPRAI
[ Mon, Oct 21st 2019
] - WOPRAI
[ Mon, Oct 21st 2019
] - WOPRAI
[ Mon, Oct 21st 2019
] - WOPRAI
Fri, October 18, 2019
[ Fri, Oct 18th 2019
] - WOPRAI
[ Fri, Oct 18th 2019
] - WOPRAI
[ Fri, Oct 18th 2019
] - WOPRAI
[ Fri, Oct 18th 2019
] - WOPRAI
[ Fri, Oct 18th 2019
] - WOPRAI
[ Fri, Oct 18th 2019
] - WOPRAI
[ Fri, Oct 18th 2019
] - WOPRAI
[ Fri, Oct 18th 2019
] - WOPRAI
[ Fri, Oct 18th 2019
] - WOPRAI
[ Fri, Oct 18th 2019
] - WOPRAI
[ Fri, Oct 18th 2019
] - WOPRAI
[ Fri, Oct 18th 2019
] - WOPRAI
[ Fri, Oct 18th 2019
] - WOPRAI
[ Fri, Oct 18th 2019
] - WOPRAI
[ Fri, Oct 18th 2019
] - WOPRAI
[ Fri, Oct 18th 2019
] - WOPRAI
[ Fri, Oct 18th 2019
] - WOPRAI
[ Fri, Oct 18th 2019
] - WOPRAI
[ Fri, Oct 18th 2019
] - WOPRAI
Michael King Maintained (SYRS) at Buy with Decreased Target to $160 on, Oct 18th, 2019
Michael King of JMP Securities, Maintained "Syros Pharmaceuticals, Inc." (SYRS) at Buy with Decreased Target from $180 to $160 on, Oct 18th, 2019.
Michael, nor any peers, have made any analyst calls on SYRS in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources
Similar Stocks and Investing Articles
[ Thu, Oct 17th 2019
] - WOPRAI
[ Fri, Oct 11th 2019
] - WOPRAI
[ Wed, Oct 09th 2019
] - WOPRAI
[ Tue, Oct 08th 2019
] - WOPRAI
[ Mon, Oct 07th 2019
] - WOPRAI
[ Thu, Oct 03rd 2019
] - WOPRAI
[ Tue, Oct 01st 2019
] - WOPRAI
[ Mon, Apr 20th 2015
] - WOPRAI
[ Tue, Oct 14th 2014
] - WOPRAI